1. Diana, Paula, Ribeiro Carneiro, Thaise Nayane, Cerutti, Janete Maria, Kuroshu, Reginaldo Massanobu, Carvalheira, Gianna Maria Griz. 2023. Transcriptomic analysis reveals that NIBAN1 overexpression is associated with BRAFV600E mutation and increases the aggressiveness of thyroid cancer. In Genes & diseases, 11, 101094. doi:10.1016/j.gendis.2023.101094. https://pubmed.ncbi.nlm.nih.gov/38425426/
2. Wang, Qianying, Zou, Baojuan, Wei, Xiaoya, Yue, Zhihui, Sun, Liangzhong. 2023. Identification of renal cyst cells of type I Nephronophthisis by single-nucleus RNA sequencing. In Frontiers in cell and developmental biology, 11, 1192935. doi:10.3389/fcell.2023.1192935. https://pubmed.ncbi.nlm.nih.gov/37583898/
3. Tong, Shiyu, Yin, Hongling, Fu, Jun, Li, Yangle. 2022. Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer. In Journal of Cancer, 13, 1103-1118. doi:10.7150/jca.66248. https://pubmed.ncbi.nlm.nih.gov/35281857/
4. Cevik, Mehtap, Gunduz, Meliha Koldemir, Deliorman, Gokce, Susleyici, Belgin. 2020. Alterations in niban gene expression as a response to stress conditions in 3T3-L1 adipocytes. In Molecular biology reports, 47, 9399-9408. doi:10.1007/s11033-020-05992-5. https://pubmed.ncbi.nlm.nih.gov/33185830/
5. Liu, Jishi, Qin, Jiao, Mei, Wenjuan, Huang, Ling, Tao, Lijian. . Expression of Niban in renal interstitial fibrosis. In Nephrology (Carlton, Vic.), 19, 479-89. doi:10.1111/nep.12266. https://pubmed.ncbi.nlm.nih.gov/24750539/
智鼠故事 
